tirzepatide surpass Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial 💡 New insight in diabetes

At Blue Sky MD, we treat GLP-1s like what they really are: hormones

It is designed to support research into mitochondrial function, receptor signaling, and metabolic pathways

Push the plunger forward to expel air and excess solution back into the vial, stopping precisely at your target dose

Eli Lilly is also launching the Zepbound Self Pay Journey Program, which lowers the price of a patients first prescription of the 7.5 mg or 10 mg vials to $499, along with any refills made within 45 days of the previous prescription cycle

Tirzepatide may also help some people experience less pain by reducing body weight and pressure on weight-bearing joints